UNLOCKING SOLUTIONS

FOR long covid

At Attomarker Ltd, we are at the forefront of diagnostic innovation, bringing cutting-edge technology to the fight against Long Covid. With our advanced multiplex testing platform, our goal is to provide healthcare providers and patients with precise, reliable, and actionable data to guide treatment decisions and improve quality of life.

Why Focus on Long Covid?

Long Covid has left millions of individuals with lingering symptoms, unanswered questions, and limited treatment options. At Attomarker, we believe that the first step toward recovery is understanding the root cause of these symptoms. That’s our passionate pursuit.

Long Covid Antibody Spectrum Test

Attomarker is developing a breakthrough diagnostic solution for Long Covid: the Long Covid Antibody Spectrum Test. The test is expected to receive UKCA Mark approval imminently, and will represent a significant step in helping to understand why an individual has Long Covid and what therapeutic options may provide benefit.

Join the Movement for Answers in Long Covid

We’re inviting individuals impacted by Long Covid, healthcare providers, and researchers to join us on this journey. By staying informed and connected with our work, you can be part of the solution to this global health challenge.

How you can get involved:

R

Subscribe for Updates

Sign up to be the first to hear about our latest developments, including the UKCA Mark approval of the Long Covid Antibody Spectrum Test.

R

Participate in Research

If you’re a Long Covid sufferer, your participation could make a difference in improving diagnostics and treatments.
R

Spread the Word

Share this page with friends, family, and healthcare professionals who may benefit from our work.

Keep Updated

Check out our LinkedIn for the latest updates on Attomarker including our Company Announcements, Investor Announcement and product launches.